{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Updates and Approvals: 2019 in Review

Activity Steps

Purpose of Activity

To highlight specific and comprehensive information about eight new drugs the US Food and Drug Administration approved in 2019.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe the actions of and the indications and contraindications for these eight newly approved drugs.
  2. List the common adverse reactions of these eight newly approved drugs.
  3. Plan the appropriate instructions for patients who are prescribed these eight newly approved drugs.
Price: $17.95


  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: NP1219A
Published: Dec 2019
Expires: 12/3/2021
Required Passing Score: 13/18 (72%)
Authors: Lauren Hartsell Crump, PharmD; Miranda Benfield, PharmD; Caleb Ramey; Ashley Arcara, BS; Sebin Yang, BA; Jenna Brown, BS; Geoffrey Mospan, PharmD, BCPS; Cortney Mospan, PharmD, BCACP, BCGP
Topics: Drug Update